Portfolios – Revelation Partners

Portfolio

Our portfolio reflects the scale and diversity of the broader healthcare venture capital market.

For over 10 years, we have created customized solutions for venture funds, corporations, limited partnership interests, operating companies, and individual shareholders.

Active
Exited

Medical Devices

Biopharmaceuticals

Diagnostics & Life Science Tools

Healthcare IT & Services

Consumer Health

Medical Devices

Biopharmaceuticals

Diagnostics & Life Science Tools

Healthcare IT & Services

Load More

Load More

Companies rely on long-term support from their capital partners.

Not all investors have the same strategic objectives or time horizon.

Our Solutions

Structure and participate in equity financings
Realign the investor base to fit a company’s growth objectives
Provide follow-on capital for existing investors that lack reserves

We pride ourselves in responsiveness, problem-solving, and delivering results. We tailor solutions to maximize outcomes for the counterparties and companies who we support.

News

Screenshot 2024-04-03 134856

VC Secondary Market Partner Perspectives: Mike Boggs

New-Product-image

Otsuka and Click Therapeutics Announce the U.S. Food and Drug Administration (FDA) Clearance of RejoynTM, the First Prescription Digital Therapeutic Authorized for the Adjunctive Treatment of Major Depressive Disorder (MDD) Symptoms

Screenshot 2024-03-26 085921

Hildred Capital Raises $750 Million Continuation Fund

Screenshot 2024-03-22 135127

Nouscom extends Series C round to $82m for cancer vaccine trials

Mission-Therapeutics-raises-25

Mission Therapeutics raises £25.2m to enhance power of mitochondria

Untitled design (3)

Revelation Partners Expands Team and Promotes Internal Talent

sprint-product-with-lead

SPR® Therapeutics Announces $85 Million in Additional Funding to Advance Rapid Commercial Expansion of the SPRINT® PNS System

Revelation Partners Expands Team with Hire of Andrew Olson, Partner, Chief Financial Officer & Chief Operating Officer

Nouscom

Nouscom Raises €67.5m in Series C Financing

Untitled design (3)

Revelation Partners Closes $608 Million Fund, Surpassing $500 Million Target

Get Started